Fluorescent immunohistochemical staining revealed that TFE3 was indeed detectable in nuclei of PROX1+D2-40- VECs from BHD patients (Fig. 7i–n). This evidence concerns the gene TFE3 and Birt-Hogg-Dube syndrome.